Sök artiklar i SveMed+

Observera: SveMed+ upphör att uppdateras!



Aferesebehandling ved alvorlig hyperkolesterolemi
Engelsk titel: Apheresis in severe hypercholesterolaemia Läs online Författare: Graesdal A ; Hovland A ; Björbaek E Språk: Nor Antal referenser: 19 Dokumenttyp: Översikt UI-nummer: 04061238

Tidskrift

Tidsskrift for Den Norske Laegeforening 2004;124(8)1085-7 ISSN 0029-2001 E-ISSN 0807-7096 KIBs bestånd av denna tidskrift Denna tidskrift är expertgranskad (Peer-Reviewed)

Sammanfattning

INTERPRETATION : LDL apheresis should be available in all health regions of Norway and the treatment should be known to all those who treat severe hypercholesterolaemia or coronary artery disease. RESULTS : LDL apheresis seems a safe and effective way of lowering LDL cholesterol. Mortality and morbidity is reduced in selected patient groups. Quite probably, too few Norwegian patients are offered this treatment. MATERIAL AND METHODS : We share some of our own experience with this treatment and then review the literature regarding LDL apheresis. BACKGROUND : Hypercholesterolaemia is usually successfully treated with statins but in some cases the medication has insufficient cholesterol-lowering effect or is not well tolerated. In these instances LDL apheresis is an option.